ADC Therapeutics SA Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: ADC Therapeutics SA quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q4 2024.
ADC Therapeutics SA Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $8.35M, a 20.5% decline year-over-year.

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$8.35M	-$2.16M	-20.5%	Dec 31, 2024	10-K	2025-03-27
Q3 2024	$9.19M			Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$9.69M			Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$10.1M			Mar 31, 2024	10-Q	2024-05-06
Q4 2023	$10.5M	+$3.61M	+52.2%	Dec 31, 2023	10-K	2025-03-27
Q4 2022	$6.91M			Dec 31, 2022	10-K	2024-03-13

Showing 1 to 6 of 6 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.